CEACAM5 and lung carcinoma: The effectiveness of two anti-Id mAbs, mAb 3H1 (CeaVac) and 11D10 (TriAb), which are designed to mimic carcinoembryonic antigen (CEA) and human milk fat globule protein (HMGF), respectively, was assessed in lung cancer patients.